Searchable abstracts of presentations at key conferences in endocrinology

ea0081p336 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Is there a relationship between nonalcoholic fatty liver disease (NAFLD) and atheroma disease?

Leon Mengibar Josep , Lopez Carolina , Zorzano Marta , Soler Beunza Ana Gloria , De La Fuente Maricruz , Herrerias Fernando , Vilardell Felip , Santamaria Maite , Lecube Albert

Introduction: Over the last few years, there are some studies that suggests a close connection between Nonalcoholic Liver Disease (NAFLD) and increased cardiovascular (CV) risk in population with obesity. Indeed, these two conditions share common drivers, most notably insulin resistance and other elements of the metabolic syndrome. Notwithstanding the above, this affirmation does not have solid scientific evidence. The proliferation of Vasa Vasorum (VV) in the adventitial laye...

ea0081p203 | Thyroid | ECE2022

Transoral endoscopic thyroidectomy (TOETVA) in thyroid cancer, our view as endocrinologists

Mallea-Gil Susana , Sanchez Yamila , Coca Bibiana , de los Angeles Sosa Maria , Palazzo Adriana , Rossi Javier , Marta Aparicio Maria , Sankowicz Silvina , Estevez Samanta , Ballarino Carolina

Recent progress in surgical technology has resulted in new techniques as transoral endoscopic thyroidectomy (TOETVA) that is an option for patientsÂ’ cosmetic requests. We evaluated patients with thyroid cancer who underwent thyroidectomy by TOETVA approach and their follow-up. Retrospective study, 5 patients were included, Bethesda classification in FNAC resulted: 2 patients with VI category (CAT), 2: V CAT and 1: III CAT. All patients were operated by TOETVA between 2020...

ea0081ep252 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Comparative analysis of characteristics of pregnant women with pathological oral glucose tolerance test vs negative oral glucose tolerance test in a trimester of 2019

Simon Frapolli Victor Jose , Ignacio Martinez Montoro Jose , Picon Cesar Maria Jose , Gutierrez Repiso Carolina , Suarez Arana Maria , Tinahones Madueno Francisco Jose , Molina Vega Maria

Introduction: Gestational diabetes mellitus (GDM) is the metabolic disorder most frequently associated with pregnancy, presenting important maternal and fetal implications. Strict glycemic control through lifestyle measures and/or pharmacotherapy is essential to achieve adequate obstetric-perinatal results. The objective of this study is to compare baseline characteristics and perinatal results in patients diagnosed with GDM after performing oral glucose tolerance test (OGTT) ...

ea0084ps2-08-75 | Thyroid Cancer BASIC | ETA2022

PD-L1 and MCL-1 markers and the relationship with prognostic characteristics of differentiated thyroid carcinoma

Engelbrecht Zantut Wittmann Denise , Siqueira Barreto Icleia , Carolina Laus Ana , Moreno Daniel , Moma Camila , Maia Frederico , Vera Montalli Assumpcao Ligia , Reis Rui

Objectives: MCL-1 and PD-L1 proteins are related to carcinogenesis mechanisms in differentiated thyroid carcinoma (DTC). Tumor antigens stimulate the expression of PD-1 in immune cells, which binds to PD-L1 of tumor cells, inducing immune escape from the tumor. MCL-1, an anti-apoptotic member of the BCL-2 family and has a high oncogenic potential. The relationship of these markers with prognosis in DTC remains unknown. We aim to evaluate the clinical utility of immunohistochem...

ea0084ps2-08-76 | Thyroid Cancer BASIC | ETA2022

Double mutation of the TERT promoter in extremely aggressive papillary thyroid carcinoma

Engelbrecht Zantut Wittmann Denise , Carolina Laus Ana , Moreno Daniel , Siqueira Barreto Icleia , Moma Camila , Maia Frederico , Etchebehere Elba , Vera Montalli Assumpcao Ligia , Reis Rui

Objectives: BRAFV600E mutation is present in 50% of aggressive papillary thyroid carcinoma(PTC). TERT promoter (pTERT) mutations (C228T, C250T) are related to cancer growth and reduced overall- and disease-free survivals in differentiated thyroid carcinomas(DTC). We report a patient with an extremely aggressive PTC presenting in the primary lesion two pTERT mutations (C228T and C250T), and absence of BRAFV600E.<p class="abstext"...

ea0090rc1.4 | Rapid Communications 1: Diabetes, Obesity, Metabolism and Nutrition 1 | ECE2023

Angiotensin-converting enzyme in type II diabetes: effects of combined training on cardiovascular components and blood components

Matos Andreia , Gil Angela , Alonso Isanete , P. Magalhaes Joao , Santos Ana Carolina , Ribeiro Rogerio , F. Raposo Joao , B. Sardinha Luis , Bicho Manuel

Objectives: The angiotensin-converting enzyme (ACE1) gene is one of the most studied genes in the pathogenesis of type II diabetes (T2DM) and cardiovascular disease. However, in the context of exerciSemodels in T2DM, they are not yet fully understood. We intended to characterize the genetic profile of individuals with T2DM from an inter-individual point of view using prognostic markers and cardiovascular risk. On the other hand, relate it with the profile obtained wit...

ea0090rc4.5 | Rapid Communications 4: Reproductive and Developmental Endocrinology | ECE2023

Women carrying CYP21A2 mutations display clinical findings and metabolic/hormonal profile analogous to women with non classical congenital adrenal hyperplasia and polycystic ovary syndrome

Livadas Sarantis , Goulis Dimitrios , eBelardinelli Elisabetta , Armeni Elena , Solmi Beatrice , Veneti Stavroula , Lambrinoudaki Irene , Cecchetti Carolina , Macut Djuro P. , Gambineri Alessandra

Heterozygotes carrying CYP21A2 gene mutations are found in 5-10% of the general population in Mediterranean countries. Accumulating data suggest a survival advantage of this population, despite the fact that carriers of two mutations suffer from either classical or non-classical congenital adrenal hyperplasia (NC-CAH), an entity with increased mortality. In an attempt to elaborate on this issue we evaluated females of reproductive age with CYP21A2 heterozygocity (HET). We have...

ea0090p312 | Calcium and Bone | ECE2023

Teriparatide in the challenging management of hypoparathyroidism, our experience in one medical center in Argentina

Mallea-Gil Susana , Sanchez Yamila , Coca Bibiana , Lopez Cindy , de los Angeles Sosa Maria , Sankowicz Silvina , Marta Aparicio Maria , Ballarino Carolina

Hypoparathyroidism is an endocrine deficiency whose substitution treatment with PTH 1-84 is only available in compassionate use in Argentina. There is a subgroup of patients in which the conventional therapy with calcium, calcitriol, phosphorous chelators, magnesium and diuretics does not reach an adequate clinical and/or biochemical compensation. Although teriparatide (PTH 1-34) is not approved for patients with hypoparathyroidism, it is a plausible therapeutic resource.<...

ea0090p78 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Epicardial Fat, a cardiovascular risk factor with implications in kidney function

Perdomo Carolina M. , Martin-Calvo Nerea , Ezponda Casajus Ana , Mendoza Francisco J. , Bastarrika Aleman Gorka , de Assuncao Guilherme V. , Garcia-Fernandez Nuria , Fruhbeck Gema , Escalada Javier

Aim: Epicardial adipose tissue (EAT) has important physiologic functions, nonetheless, excessive EAT leads to a proinflammatory state with adverse effects on the myocardium. EAT has also been associated with adverse outcomes in chronic kidney disease (CKD) patients. We think that visceral adipose tissue (VAT) and organ-specific ectopic fat plays an important role in cardiorenal dysfunction. The aim of our study is to analyse the relationship between EAT and the risk of develop...

ea0090ep90 | Adrenal and Cardiovascular Endocrinology | ECE2023

Multifocal paraganglioma due to SDHB mutation: On purpose of one clinical case

Ferreira-Ocampo Pablo , Doejo Marciales Sandra Carolina , Barra Malig Solange Fabiola , Astunague Condori Remy Edward , Chicharro Pablo Lois , Ruiz Francisca Almodovar , Gorgojo Martinez Juan Jose , Salinas Helena Requejo

The mutations of succinate dehydrogenase subunits (SDHA, SDHB, SDHC, SDHD) are linked with a predisposition to develop pheochromocytoma and paraganglioma, often in diferent locations of the body. With greater acces to genetic tests, current estimations suggest that 40-50% of pheocromocytoma and paraganglioma cases are inherited and half of them are due to SDH mutations. These mutations can be associated with other tumours like renal carcinomas, gastrointestinal stroma tumours ...